Skip to main content

Lupus (Systemic Lupus Erythematosus) and cannabis in Arizona

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
2.5 oz per 14-day supply
POSSESSION
$150/yr
STATE FEE
5–14 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Arizona statute and program

The Arizona Medical Marijuana Program is the operating authority for Arizona patient certification. The authoritative legal text is: A.R.S. Title 36 Chapter 28.1: Arizona Medical Marijuana Act.

What the evidence says about cannabis and Lupus (Systemic Lupus Erythematosus)

Systemic lupus erythematosus (SLE), commonly called lupus, is a chronic autoimmune disease in which the immune system produces autoantibodies that attack the body's own tissues. Inflammation can affect joints, skin, kidneys, blood, lungs, heart, and the nervous system. Lupus is a relapsing-remitting disease — patients experience flares and periods of relative quiescence.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Lupus (Systemic Lupus Erythematosus) page.

How to qualify in Arizona

The Arizona Medical Marijuana Program requires the following registration steps for a Lupus (Systemic Lupus Erythematosus) patient (or any qualifying diagnosis):

  1. Get a written certification from an Arizona-licensed physician. Under A.R.S. §36-2801 et seq. (Arizona Medical Marijuana Act, Proposition 203 of 2010), any Arizona-licensed allopathic physician, osteopathic physician, naturopathic physician, or homeopathic physician may complete the Physician Certification Form. The physician must establish a bona-fide physician-patient relationship and certify one of the enumerated debilitating medical conditions: cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s, Alzheimer’s, cachexia, severe and chronic pain, severe nausea, seizures, severe and persistent muscle spasms, or PTSD.
  2. Apply through the AZDHS online portal. The patient creates an account at the Arizona Department of Health Services (AZDHS) Medical Marijuana Program online portal, uploads the Physician Certification Form, an Arizona driver license or state ID, and a passport-style photograph. Caregivers register separately and pass a fingerprint-based criminal history records check.
  3. Pay the $150 state registration fee. The two-year Arizona medical marijuana patient ID card fee is $150 (reduced to $75 for SNAP participants). Caregivers pay $200 for the two-year card and the fingerprint check. The 2024 AZDHS rule revisions kept the two-year card validity (extended from one year in 2019) which keeps total annual cost lower than most comparable states.
  4. Receive the card and purchase from an Arizona dispensary. Arizona medical marijuana patient ID cards are typically issued within 5 to 10 business days of complete application. With the card, patients may purchase up to 2.5 ounces every 14 days from any of the licensed Arizona medical dispensaries. Adult-use retail is legal statewide for adults 21+ under Proposition 207 (2020); medical patients retain a lower 6% medical excise tax versus the 16% adult-use excise tax plus access to higher-potency edibles. Arizona honors out-of-state medical cards for non-resident visitors (visitors may possess but not purchase).
State registration fee
$150
Physician visit (typical)
$100–$250
Certification to card
5–14 days
Out-of-state patients
Eligible
Minors
Eligible with caregiver

For full Arizona registration steps, fees, and reciprocity rules, see the Arizona cannabis-laws page.

ICD-10 code

A certifying physician documenting Lupus (Systemic Lupus Erythematosus) for the Arizona medical cannabis program will typically record ICD-10 M32.9 or SNOMED-CT 55464009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Arizona list Lupus (Systemic Lupus Erythematosus) as a qualifying condition for medical cannabis?

No. Arizona's qualifying-condition list does not currently include Lupus (Systemic Lupus Erythematosus), and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Lupus (Systemic Lupus Erythematosus) in Arizona have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Arizona program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a Arizona medical marijuana card for Lupus (Systemic Lupus Erythematosus)?

Because Arizona does not currently list Lupus (Systemic Lupus Erythematosus) as a qualifying condition, a card for Lupus (Systemic Lupus Erythematosus) alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Arizona who is registered with Arizona Medical Marijuana Program and willing to evaluate Lupus (Systemic Lupus Erythematosus) cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Arizona honors out-of-state medical cards under its reciprocity rules — uncommon, and worth verifying before relying on it. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Lupus (Systemic Lupus Erythematosus)?

For Lupus (Systemic Lupus Erythematosus), evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Lupus (Systemic Lupus Erythematosus) lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Lupus (Systemic Lupus Erythematosus) should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Lupus (Systemic Lupus Erythematosus) and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Lupus (Systemic Lupus Erythematosus); the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. A.R.S. Title 36 Chapter 28.1: Arizona Medical Marijuana Actaccessed May 15, 2026
  2. Arizona Department of Health Services: Medical Marijuana Programaccessed May 15, 2026
  3. A.R.S. §28-1381: Driving under the influenceaccessed May 17, 2026
  4. Arizona Department of Agriculture: Industrial Hemp Programaccessed May 17, 2026
  5. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupusaccessed May 18, 2026
  6. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 18, 2026

    “Substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults.”

  7. Lupus Foundation of America: Marijuana and Lupusaccessed May 18, 2026
  8. American College of Rheumatology: 2023 Guideline for SLE Management (executive summary)accessed May 18, 2026
  9. MedlinePlus: Systemic lupus erythematosusaccessed May 18, 2026